Valeant CEO subpoenaed to testify before U.S. Senate panel

Valeant CEO subpoenaed to testify before U.S. Senate panel


The chief executive of Valeant Pharmaceuticals International Inc, which is under scrutiny for dramatically hiking the price of older drugs, has been summoned to testify at a U.S. congressional hearing on April 27, the panel said on Monday. The Senate Special Committee on Aging hearing comes as the Canadian-based company is coping with a variety of federal investigations into its accounting practices that led to a restatement and delays in the filing of its annual report.



from Biotech News